Both in Pharmaceuticals
Trevi Therapeutics vs PERRIGO
Over the past year TRVI returned +61.1% and PRGO returned −31.0%; their daily moves had a correlation of 0.10.
TRVI +61.1% PRGO −31.0%Growth of $1, one year, split-adjusted
| Metric | TRVI | PRGO |
|---|---|---|
| Price | $14.42 | $15.00 |
| Market cap | $2.05B | $2.08B |
| Today | +0.14% | −0.66% |
| 1 month | −14.1% | +3.6% |
| 6 months | +28.9% | +54.3% |
| Year to date | +15.2% | +7.8% |
| 1 year | +64.4% | −30.1% |
| Revenue growth (YoY) | — | −3.2% |
| Gross margin | — | 30.7% |
| Net margin | — | 7.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.5× |
| Net cash | $318.9M | -$2.90B |
| Dividend yield | — | 7.73% |
| Volatility (60d) | 59.0% | 62.6% |
| Short % of float | 12.3% | 16.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).